# Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

> **NCT06079242** · — · NOT_YET_RECRUITING · sponsor: **GrandPharma (China) Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DEVICE:** Resin microspheres containing yttrium-90 (Y-90)

## Key facts

- **NCT ID:** NCT06079242
- **Lead sponsor:** GrandPharma (China) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-15
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-04-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06079242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06079242, "Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06079242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*